Chen‐Lu Lian

457 total citations
47 papers, 304 citations indexed

About

Chen‐Lu Lian is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Chen‐Lu Lian has authored 47 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cancer Research, 20 papers in Pathology and Forensic Medicine and 19 papers in Oncology. Recurrent topics in Chen‐Lu Lian's work include Breast Cancer Treatment Studies (25 papers), Breast Lesions and Carcinomas (19 papers) and Head and Neck Cancer Studies (13 papers). Chen‐Lu Lian is often cited by papers focused on Breast Cancer Treatment Studies (25 papers), Breast Lesions and Carcinomas (19 papers) and Head and Neck Cancer Studies (13 papers). Chen‐Lu Lian collaborates with scholars based in China, Hong Kong and United States. Chen‐Lu Lian's co-authors include San‐Gang Wu, Zhen‐Yu He, Jian Lei, Wen‐Wen Zhang, San‐Gang Wu, Juan Zhou, Jiayuan Sun, Yongxiong Chen, Ping Zhou and Jun Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Chen‐Lu Lian

45 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chen‐Lu Lian China 11 165 115 76 72 69 47 304
Tosol Yu South Korea 9 56 0.3× 137 1.2× 99 1.3× 68 0.9× 67 1.0× 21 326
A. Caldara Italy 9 100 0.6× 172 1.5× 124 1.6× 70 1.0× 71 1.0× 26 309
Minh Thi Tieu Australia 10 118 0.7× 86 0.7× 50 0.7× 59 0.8× 61 0.9× 16 345
Thomas C. Putti Singapore 12 61 0.4× 140 1.2× 90 1.2× 67 0.9× 75 1.1× 16 367
Johannes A. Rijken Netherlands 10 110 0.7× 64 0.6× 43 0.6× 88 1.2× 229 3.3× 41 331
Xing‐Li Yang China 12 48 0.3× 122 1.1× 75 1.0× 175 2.4× 101 1.5× 23 315
Songran Liu China 9 74 0.4× 147 1.3× 91 1.2× 65 0.9× 78 1.1× 28 328
Shengfu Huang China 11 46 0.3× 86 0.7× 98 1.3× 152 2.1× 122 1.8× 27 344
Haolin Yan China 10 63 0.4× 97 0.8× 118 1.6× 173 2.4× 109 1.6× 21 302
L. Ciuffreda Italy 8 74 0.4× 208 1.8× 52 0.7× 32 0.4× 54 0.8× 23 333

Countries citing papers authored by Chen‐Lu Lian

Since Specialization
Citations

This map shows the geographic impact of Chen‐Lu Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen‐Lu Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen‐Lu Lian more than expected).

Fields of papers citing papers by Chen‐Lu Lian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen‐Lu Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen‐Lu Lian. The network helps show where Chen‐Lu Lian may publish in the future.

Co-authorship network of co-authors of Chen‐Lu Lian

This figure shows the co-authorship network connecting the top 25 collaborators of Chen‐Lu Lian. A scholar is included among the top collaborators of Chen‐Lu Lian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen‐Lu Lian. Chen‐Lu Lian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Ping, et al.. (2024). Efficacy of nimotuzumab added to concurrent chemoradiotherapy after induction chemotherapy for patients with locally advanced nasopharyngeal carcinoma.. Journal of Clinical Oncology. 42(16_suppl). 6024–6024. 1 indexed citations
2.
Lian, Chen‐Lu, Guiping Chen, Rui Zhou, et al.. (2024). Efficacy of Thyroid Hormone Replacement Therapy in Nasopharyngeal Carcinoma Patients with Radiation-Induced Subclinical Hypothyroidism. Experimental and Clinical Endocrinology & Diabetes. 132(11). 614–621.
3.
Lian, Chen‐Lu, Rengong Zhuo, Rui Zhou, et al.. (2023). Risk factors of early thyroid dysfunction after definitive radiotherapy in nasopharyngeal carcinoma patients. Head & Neck. 45(9). 2344–2354. 2 indexed citations
4.
Lian, Chen‐Lu, Haiyan Zhang, Jun Wang, et al.. (2021). Staging for Breast Cancer With Internal Mammary Lymph Nodes Metastasis: Utility of Incorporating Biologic Factors. Frontiers in Oncology. 10. 584009–584009. 4 indexed citations
5.
Wu, San‐Gang, Jian Lei, Hua Li, et al.. (2021). circ-PTK2 (hsa_circ_0008305) regulates the pathogenic processes of ovarian cancer via miR-639 and FOXC1 regulatory cascade. Cancer Cell International. 21(1). 277–277. 18 indexed citations
6.
Li, Guanqiao, Jia Yao, Ping Zhou, et al.. (2021). Distribution, Chemotherapy Use, and Outcome of the 21-Gene Recurrence Score Between Chinese and White breast Cancer in the United States. Clinical Breast Cancer. 22(3). 279–287. 2 indexed citations
7.
Zhou, Ping, et al.. (2021). Rare Metastasis to the Submandibular Gland in Oral Squamous Cell Carcinoma. Frontiers in Oncology. 11. 728230–728230. 1 indexed citations
8.
9.
Lian, Chen‐Lu, et al.. (2020). Integration the biologic factors into the staging of breast cancer patients with ipsilateral supraclavicular lymph node metastasis. Journal of Cancer. 11(23). 6834–6840. 1 indexed citations
10.
Lian, Chen‐Lu, Lei Zhang, Jun Wang, et al.. (2020). Aggressive Local Treatment Improves Survival in Stage IV Breast Cancer With Synchronous Metastasis. Frontiers in Oncology. 10. 522580–522580. 5 indexed citations
11.
12.
Li, Feng‐Yan, et al.. (2020). Real-world impact of postmastectomy radiotherapy in T1–2 breast cancer with one to three positive lymph nodes. Annals of Translational Medicine. 8(7). 489–489. 6 indexed citations
13.
Lian, Chen‐Lu, Feng Chi, Ping Zhou, et al.. (2020). Prognostic and Predictive Value of the American Joint Committee on Cancer Pathological Prognostic Staging System in Nodal Micrometastatic Breast Cancer. Frontiers in Oncology. 10. 570175–570175. 2 indexed citations
14.
Wang, Jun, et al.. (2020). Cognitive dysfunction in patients with nasopharyngeal carcinoma after induction chemotherapy. Oral Oncology. 111. 104921–104921. 9 indexed citations
15.
Zhou, Juan, Jian Lei, Jun Wang, et al.. (2020). Bioinformatics-Based Discovery of CKLF-Like MARVEL Transmembrane Member 5 as a Novel Biomarker for Breast Cancer. Frontiers in Cell and Developmental Biology. 7. 361–361. 6 indexed citations
16.
He, Zhen‐Yu, Chen‐Lu Lian, Jian Lei, et al.. (2020). Incorporation of biologic factors for the staging of de novo stage IV breast cancer. npj Breast Cancer. 6(1). 43–43. 7 indexed citations
17.
18.
Guo, Rui, Chen‐Lu Lian, Zhen‐Yu He, et al.. (2019). Lymph Node Status and Outcomes for Nasopharyngeal Carcinoma According to Histological Subtypes: A SEER Population-Based Retrospective Analysis. Advances in Therapy. 36(11). 3123–3133. 16 indexed citations
19.
Wang, Jun, et al.. (2019). The Effect of Post-mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: An Analysis of SEER Database. Frontiers in Oncology. 9. 747–747. 12 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tosol Yu Breakdown of academic impact, for papers by A. Caldara Breakdown of academic impact, for papers by Minh Thi Tieu Breakdown of academic impact, for papers by Thomas C. Putti Breakdown of academic impact, for papers by Johannes A. Rijken Breakdown of academic impact, for papers by Xing‐Li Yang Breakdown of academic impact, for papers by Songran Liu Breakdown of academic impact, for papers by Shengfu Huang Breakdown of academic impact, for papers by Haolin Yan Breakdown of academic impact, for papers by L. Ciuffreda
Rankless by CCL
2026